Gilead Sciences, Inc. to Present Data on Oncology Pipeline at American Society of Hematology Annual Meeting
Published: Nov 07, 2013
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that 10 abstracts describing the company's investigational agents for several hematological malignancies have been selected for presentation at the Annual Meeting of the American Society of Hematology (ASH) taking place December 7-10 in New Orleans.
Help employers find you! Check out all the jobs and post your resume.